• Strong 2QFY27 expected, driven by seasonal demand and product launches
• Chinese competition and bad weather threaten UPL’s recovery
• Adequate liquidity for December USD loan repayment

 

 

A recovery in pesticide sales volume could help India-listed global agrochemicals maker UPL Ltd convert its seasonal inventory build-up into cash and support further deleveraging.

Management expects a strong, volume-led 2QFY27 through 30 September, supported by seasonal demand and product launches, although competition from Chinese agrochemical producers and bad weather could hurt volume growth, delay cash conversion and debt reduction.

UPL is likely to report its 2QFY27 results in early November based on its historical reporting schedule.

The company’s aggregate sales volumes need to grow about 3%–8% over the remaining nine months of FY27 through 31 March to achieve management’s 7%–11% full-year revenue growth target excluding FX effects, according to Debtwire’s calculation (table 1). This estimate assumes modest low-single to mid-single-digit price increases for crop protection, as indicated by management on a 3 August earnings call. Since crop protection accounts for more than 80% of group revenue, this pricing assumption is used as a proxy for the group.

UPL’s revenue rose 10.6% YoY to INR 101.8bn (USD 1.07bn) in 1QFY27 through 30 June 2026 from INR 92.2bn in 1QFY26, within management’s 10%–14% growth guidance for 1QFY26 in INR terms, provided in 4QFY26. The growth was driven mainly by favourable foreign exchange movements, which contributed about 10%, while a 3% increase in prices partially offset a 3% decline in sales volumes. Net debt/EBITDA improved to 2.4x as of 30 June 2026 from 2.6x a year earlier, marking progress towards management’s medium-term leverage target of below 1.5x.

Working capital continued to absorb cash. UPL’s cash-conversion cycle lengthened to 110 days in 1QFY27, from 57 days in 4QFY26 and 86 days in 1QFY26 (chart 1).

Inventory days increased by 13 days and receivable days by 12 in 1QFY27 from 1QFY26, while payable days remained broadly unchanged YoY. Inventory rose 26.5% YoY to INR 177.68bn, reflecting higher replacement costs for raw material inputs and stock accumulation ahead of anticipated 2Q restocking by distributors. Meanwhile, the heatwave weighed on European crop-protection sales, and a slow start to the monsoon delayed India’s seed season. These disruptions may also have contributed to higher receivable days, as lower or delayed sales can inflate the metric when outstanding customer balances remain the same.

The INR 78.22bn QoQ increase in working capital was funded largely through INR 56.45bn in additional short-term working capital borrowings and a INR 17.99bn reduction in cash and equivalents.

A slower-than-expected volume recovery could leave inventory unsold for longer, delaying cash generation as working capital facilities approach maturity. UPL may then need to renew these facilities, draw on committed lines or increase receivables factoring to bridge the funding gap, potentially delaying deleveraging. Non-recourse receivables factoring increased to INR 67.55bn as of 30 June 2026, from INR 59.4bn a year earlier. While factoring supports liquidity by bringing forward cash receipts, greater reliance on it would leave UPL more exposed to changes in the availability and cost of this funding.

An oversupply of agrochemicals in China and the overall bad weather remain risks to UPL’s expected recovery. China’s domestic agrochemical production rose 12% YoY to 4.12m tons in 2025, while its agrochemical exports rose 13.3% YoY to CNY 72.53bn (USD 10.83bn) in 2025 (chart 2). Greater availability of competitively priced Chinese products could pressure UPL’s selling prices and market share.

Separately, bad weather, including potential El Niño-related disruption, could reduce planting/crop yields, weaken farmers’ purchasing power and discourage distributor restocking. Together, these pressures could slow inventory conversion into cash and delay further deleveraging.

UPL has two USD bonds outstanding, both issued by 77.8%-owned UPL Corp Ltd: originally USD 300m 4.5% due-March 2028s and USD 500m 4.625% due-June 2030s. The due-2028s were indicated at ~96.25c on 12 October, equivalent to a YTM of 7.35%, while the due-2030s were indicated at ~90.72c, equivalent to a YTM of 7.56%.

 

Liquidity appears adequate for December USD loan repayment

UPL Ltd’s liquidity appears adequate to meet the company’s near-term obligations, including its USD 500m (INR 47.64bn) due-December 2026 loan. The company’s liquidity is supported by INR 42.6bn of cash and INR 6.6bn liquid investments as of 30 June and continued access to bank funding.

Liquidity is projected to total about INR 20bn by 30 June 2027, per Debtwire’s estimates, which assume INR 72bn of operating cash flow after tax and interest but before working capital movements in the 12 months to that date. The liquidity estimate incorporates the repayment of the USD 500m (INR 47.3bn) sustainability-linked loan due in December 2026, INR 5.1bn of lease repayments, INR 43.6bn of capital expenditure and acquisition spending, and INR 5bn of FY26 final dividends.

Acquisition spending includes the USD 110m (INR 10.48bn) purchase of seed company Hytech Egypt by UPL’s step-down subsidiary Advanta Holdings B.V. announced on 15 August. The forecast assumes INR 13bn of incremental working capital requirements is fully funded through additional bank drawings and that existing working capital borrowings are renewed.

UPL also has a USD 300m three-year committed revolving credit facility (RCF) and USD 2bn of uncommitted working capital lines. While these facilities provide potential funding flexibility, no liquidity uplift is assumed because the undrawn amounts and their availability have not been disclosed. Potential proceeds from an Advanta IPO are also excluded from Debtwire’s liquidity analysis. While the planned IPO received the Securities and Exchange Board of India (SEBI) approval on 3 June, the timing of completion and cash receipt remain uncertain.

The due-December 2026 sustainability-linked loan is UPL’s only disclosed USD term-debt maturity in FY27. Two maturities follow in FY28: a USD 500m bank loan due in September 2027 and USD 276m outstanding on the 4.5% senior notes due in March 2028.

 

UPL offers potential relative value versus Nufarm; shorter-dated notes stand out

As of 9 October, UPL’s due-June 2030 notes traded at a Z-spread of 246bps, around 20bps wider than Australia-listed agrichemicals and seeds producer Nufarm Ltd’s due-January 2030 notes, despite UPL’s lower gross leverage. UPL’s total debt/EBITDA was 3.07x as of 30 June versus 4.67x for Nufarm as of 31 March 2026, as per its latest financials (chart 3). UPL also has a shorter cash conversion cycle, at 110 days versus Nufarm’s 153 days, although UPL’s cycle deteriorated YoY while Nufarm’s improved.

Within UPL’s curve, the due-March 2028 notes were at a 238bps z-spread, only 8bps less than the 2030s, providing a comparatively attractive spread compensation for the shorter maturity.

Chinese state-backed and Switzerland-based agrochemicals and seeds producer Syngenta Group Co Ltd’s 2042 and 2048 notes trade at broadly similar spreads of 249bps and 235bps, respectively, although their longer maturities make them less direct comparables.

 

Key takeaways from UPL’s 1QFY27 through 30 June 2026 results:

• USD-bond-issuing global crop-protection unit UPL Corp’s 1QFY27 revenue grew 7.0% YoY to INR 63.7bn from INR 59.6bn a year earlier, as a 14% positive foreign-exchange impact more than offset a 7% decline in volumes, while pricing remained flat. Improved product margin and regional mix lifted EBITDA 37.8% YoY to INR 5.3bn in 1QFY27. Latin America remained the largest contributor, accounting for 35.6% of 1QFY27 revenue, followed by Europe at 22.4%.
• India crop-protection unit UPL SAS’ revenue was broadly flat as higher prices offset weaker volumes. UPL SAS revenue was up 0.4% YoY at INR 11.4bn in 1QFY27. Improved pricing and mix boosted EBITDA growth of 34.4% to INR 3.4bn in 1QFY27.
• Seeds and post-harvest business Advanta Enterprises’ revenue increased 25.6% YoY to INR 17.5bn in 1QFY27 and EBITDA rose 24.7% YoY to INR 3.6bn, supported by higher pricing and volume growth in corn, rice and sunflower sales.
• Specialty chemicals producer SUPERFORM’s revenue grew 14.1% YoY to INR 29.2bn, driven by specialty chemicals and active-ingredient pricing, but higher overheads limited EBITDA growth to 7.5% YoY to INR 3.6bn.
• The overall group generated revenue of INR 528.0bn before intercompany eliminations in 1QFY27 LTM. UPL Corp remained the largest contributor, accounting for 64.7% of revenue, followed by SUPERFORM (17.8%), Advanta (12.0%) and UPL SAS (5.4%).
• Free cash flow (FCF) deteriorated to negative INR 83.8bn in 1QFY27 from negative INR 40.4bn a year earlier, reflecting substantial working capital absorption, higher capex and increased investments. The working capital outflow was primarily driven by higher inventories and receivables ahead of the peak season, while investments rose to INR 6.7bn from INR 0.2bn, largely due to funding for associate Sinova Inovações Agrícolas S.A (Sinova). FCF is defined as operating cash flow less tax paid, interest paid, capex and investments.
• UPL’s step-down subsidiary United Phosphorus Holdings Brazil B.V agreed to invest USD 86.7m (BRL 450m/INR 8.62bn) in Sinova, a Brazilian distributor and grain reseller on or before 15 May, which would increase its economic interest from 49.97% to 55.81%, according to a 25 April 2026 company announcement. Sinova continues to be an associate as UPL will not control the entity. The injection is to strengthen Sinova’s working capital and reduce debt, following a tough operating environment over the past two years. This follows a USD 53.85m (INR 5.15bn) investment announced in February 2025, which increased UPL’s stake from 38.96% to 49.97%.
• Net debt as reported increased to INR 251.2bn as of 30 June from INR 168.56bn as of 31 March due to seasonal working capital build-up, capex and investments. Net debt was INR 232.74bn as of 30 June 2025. Net debt/EBITDA declined to 2.4x as of 30 June 2026 from 2.6x a year earlier, supported by continued EBITDA growth.
• The reorganisation of UPL’s crop-protection businesses remains on track, with the Competition Commission of India’s (CCI) approval received on 2 June 2026 and no-adverse-observation letters received from stock exchanges on 29 July 2026.
• Advanta received SEBI approval for its IPO on 3 June 2026. The company commenced investor roadshow for an IPO targeting up to USD 400m (INR 38.09bn), Bloomberg reported on 28 September. The offering will involve the sale of 36m existing shares by shareholders, representing ~10% of Advanta’s equity, with a launch potentially as early as November, according to the report.
• Mike Frank stepped down as CEO of UPL Corp effective 31 August 2026 citing personal reasons. Group Chairman and CEO Jai Shroff took over leadership of the global crop-protection business.
• Group Chief Operating Officer Toshan Tamhane also left UPL Ltd effective 31 August 2026 to “pursue entrepreneurial ventures,” according to a company filing.
• S&P on 14 August changed UPL Corp’s outlook to positive from stable, while affirming its BB issuer and senior unsecured note ratings. The change in outlook reflects expectations of “sustained earnings and a disciplined financial policy over the next 12 months,” the ratings agency stated.
• CRISIL on 2 September changed its outlook on UPL Ltd’s long-term domestic bank facilities to stable from negative, while reaffirming its AA+ rating. It also reaffirmed the A1+ rating on short-term bank facilities and the commercial paper programme.
• CARE Ratings on 25 June upgraded UPL Ltd’s domestic long-term bank facility rating to AA+ from AA with a stable outlook, while reaffirming its A1+ short-term rating.

 

Disclaimer:

This report should not be relied upon to make investment decisions. Furthermore, this report is not intended and should not be construed as investment advice. ION Analytics does not provide any investment advice, and clients should consult with their own financial advisor for matters requiring investment advice. All information is sourced from either the public domain or ION Analytics data or intelligence, and ION Analytics cannot and does not verify or guarantee the adequacy, accuracy or completeness of any source document. No representation is made that it is current, complete or accurate. The information herein is not intended to be used as a basis for investing and does not constitute an offer to buy or sell any securities or investment strategy. The information herein is for informational purposes only and ION Analytics accepts no liability whatsoever for any direct or consequential loss arising from any use of the information contained herein.